About the International Psoriasis Council

Founded in 2004, the International Psoriasis Council (IPC) is a dermatology-led, voluntary, global, nonprofit organization with a network of more than 100 psoriasis experts, thought leaders, and professionals, dedicated to improving patient care around the globe.

Through our work, we deepen the understanding of the disease and its management. We lead advancements in care by facilitating cutting-edge research, convening partners to collaborate and advocate for improved treatment, and growing capacity for psoriasis management by sharing our knowledge. Unbiased and science-based, our collective expertise and influence have a direct impact on how patients around the world are treated.

Our Vision: a world free of psoriasis.

We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them, and that ultimately a world without psoriasis is possible.

Our Mission is to improve the care of people with psoriasis worldwide, through education, research and advocacy.

Join us. Learn with us.
Let’s work together to advance psoriasis leadership and enhance patient care.

Global Psoriasis Leadership

The International Psoriasis Council is governed by a volunteer board of directors comprised of the world’s leading experts in psoriasis and others who provide business expertise to the organization.

IPC has identified additional psoriasis experts from around the world who serve in a voluntary capacity and lend their global expertise on psoriasis research, treatment, and education to support all IPC programs, events, and initiatives. IPC has designated them with the title of “Councilor .”

With more than one hundred board members and councilors from thirty-two countries , IPC embodies the global expertise of multi-specialty psoriasis key opinion leaders. These leaders include representatives from dermatology, basic science, translational research, genetics, epidemiology, cardiology, psychology, international clinical trials, and direct patient care.